LYEL filings
Corporate insider profile
Gary K. Lee Filing Activity
Latest reported as Chief Scientific Officer of Lyell Immunopharma, Inc. (LYEL).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$2,459.60
- Latest transaction
- May 11, 2026
Affiliated corporations
Reported company relationships
Transaction history
